The role of natural killer T cells in the pathogenesis of acute exacerbation of human asthma

International Archives of Allergy and Immunology

Volumn 158, Issue 2, 2012, Pages 131-141

  Koh, Young Il ^a   Shim, Jae Uoong ^a   Wi, Jeongook ^a   Kwon, Yong Eun ^b  

^a Chonnam National University Medical School   (South Korea)

^b Chosun University College of Medicine   (South Korea)

Author keywords

Asthma; Exacerbation; Infection; Natural killer T cells

Indexed keywords

ALLERGEN; EOTAXIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; ATOPY; BLOOD SAMPLING; CLINICAL ARTICLE; CONVALESCENCE; CYTOKINE PRODUCTION; DERMATOPHAGOIDES FARINAE; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; MALE; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; SPUTUM CULTURE; UPPER RESPIRATORY TRACT INFECTION;

ADULT; AGED; ASTHMA; BRONCHIAL PROVOCATION TESTS; CHEMOKINES; CYTOKINES; EOSINOPHILS; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; RESPIRATORY TRACT INFECTIONS; SPUTUM; YOUNG ADULT;

EID: 84856051354     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000330908     Document Type: Article

References (42)

1. National Asthma Education and Prevention Program: Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda, National Institutes of Health/National Heart, Lung, and Blood Institute, 2007.
2. Wark PA, Gibson PG: Asthma exacerbations. 3. Pathogenesis. Thorax 2006; 61: 909-915.
3. Lane S, Molina J, Plusa T: An international observational prospective study to determine the cost of asthma exacerbations (COAX). Respir Med 2006; 100: 434-450. (Pubitemid 43239877)
4. Skrepnek GH, Skrepnek SV: Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. Am J Manag Care 2004; 10:S129-S138. (Pubitemid 38970249)
5. Andersson F, Borg S, Stahl E: The impact of exacerbations on the asthmatic patient's preference scores. J Asthma 2003; 40: 615-623. (Pubitemid 37296149)
6. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A: Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337: 1405-1411.
7. Umetsu DT, DeKruyff RH: A role for natural killer T cells in asthma. Nat Rev Immunol 2006; 6: 953-958. (Pubitemid 44851737)
8. Kronenberg M, Gapin L: The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002; 2: 557-568. (Pubitemid 37328731)
9. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, Taniguchi M, Grusby MJ, DeKruyff RH, Umetsu DT: Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003; 9: 582-588. (Pubitemid 36597105)
10. Meyer EH, Goya S, Akbari O, Berry GJ, Savage PB, Kronenberg M, Nakayama T, DeKruyff RH, Umetsu DT: Glycolipid activation of invariant T cell receptor+ NKT cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc Natl Acad Sci USA 2006; 103: 2782-2787.
11. Pichavant M, Goya S, Meyer EH, Johnston RA, Kim HY, Matangkasombut P, Zhu M, Iwakura Y, Savage PB, DeKruyff RH, Shore SA, Umetsu DT: Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J Exp Med 2008; 205: 385-393. (Pubitemid 351281604)
12. Koh YI, Kim HY, Meyer EH, Pichavant M, Akbari O, Yasumi T, Savage PB, Dekruyff RH, Umetsu DT: Activation of nonclassical CD1d-restricted NKT cells induces airway hyperreactivity in beta 2-microglobulin-deficient mice. J Immunol 2008; 181: 4560-4569.
13. Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, DeKruyff RH, Umetsu DT: CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med 2006; 354: 1117-1129.
14. Vijayanand P, Seumois G, Pickard C, Powell RM, Angco G, Sammut D, Gadola SD, Friedmann PS, Djukanovic R: Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 1410-1422. (Pubitemid 46556326)
15. Koh YI, Shim JU, Wi JO, Han ER, Jin NC, Oh SH, Park CK, Park DJ: Inverse association of peripheral blood CD4(+) invariant natural killer T cells with atopy in human asthma. Hum Immunol 2010; 71: 186-191.
16. Koh YI, Shim JU: Association between sputum natural killer T cells and eosinophilic airway inflammation in human asthma. Int Arch Allergy Immunol 2010; 153: 239-248.
17. Global Initiative For Asthma: Global strategy for asthma management and prevention. Bethesda, National Institutes of Health/National Heart, Lung, and Blood Institute, 2002.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
19. Melillo G, Aas K, Cartier A, Davies RJ, Debelic M, Dreborg S, Kerrebijn KF, Lassen A, Pinto Mendes J, Rizzo A, et al: Guidelines for the standardization of bronchial provocation tests with allergens. An update by an international committee. Allergy 1991; 46: 321-329.
20. Boyson JE, Rybalov B, Koopman LA, Exley M, Balk SP, Racke FK, Schatz F, Masch R, Wilson SB, Strominger JL: CD1d and invariant NKT cells at the human maternal-fetal interface. Proc Natl Acad Sci USA 2002; 99: 13741-13746. (Pubitemid 35215451)
21. Magnan A, Mely L, Prato S, Vervloet D, Romagne F, Camilla C, Necker A, Casano B, Montero-Jullian F, Fert V, Malissen B, Bongrand P: Relationships between natural T cells, atopy, IgE levels, and IL-4 production. Allergy 2000; 55: 286-290. (Pubitemid 30146126)
22. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST: Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995; 151: 879-886.
23. Grunberg K, Smits HH, Timmers MC, de Klerk EP, Dolhain RJ, Dick EC, Hiemstra PS, Sterk PJ: Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 1997; 156: 609-616. (Pubitemid 27352002)
24. Trigg CJ, Nicholson KG, Wang JH, Ireland DC, Jordan S, Duddle JM, Hamilton S, Davies RJ: Bronchial inflammation and the common cold: a comparison of atopic and non-atopic individuals. Clin Exp Allergy 1996; 26: 665-676. (Pubitemid 26226581)
25. Schwarze J, Cieslewicz G, Hamelmann E, Joetham A, Shultz LD, Lamers MC, Gelfand EW: IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J Immunol 1999; 162: 2997-3004. (Pubitemid 29309329)
26. van Benten IJ, KleinJan A, Neijens HJ, Osterhaus AD, Fokkens WJ: Prolonged nasal eosinophilia in allergic patients after common cold. Allergy 2001; 56: 949-956.
27. Thomas SY, Hou R, Boyson JE, Means TK, Hess C, Olson DP, Strominger JL, Brenner MB, Gumperz JE, Wilson SB, Luster AD: CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol 2003; 171: 2571-2580. (Pubitemid 37025568)
28. Kim EY, Battaile JT, Patel AC, You Y, Agapov E, Grayson MH, Benoit LA, Byers DE, Alevy Y, Tucker J, Swanson S, Tidwell R, Tyner JW, Morton JD, Castro M, Polineni D, Patterson GA, Schwendener RA, Allard JD, Peltz G, Holtzman MJ: Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 2008; 14: 633-640. (Pubitemid 351809546)
29. Lommatzsch M, Julius P, Kuepper M, Garn H, Bratke K, Irmscher S, Luttmann W, Renz H, Braun A, Virchow JC: The course of allergen-induced leukocyte infiltration in human and experimental asthma. J Allergy Clin Immunol 2006; 118: 91-97. (Pubitemid 43946466)
30. Nocker RE, Out TA, Weller FR, Mul EP, Jansen HM, van der Zee JS: Influx of neutrophils into the airway lumen at 4 h after segmental allergen challenge in asthma. Int Arch Allergy Immunol 1999; 119: 45-53. (Pubitemid 29204583)
31. Boulay ME, Prince P, Deschesnes F, Chakir J, Boulet LP: Metalloproteinase-9 in induced sputum correlates with the severity of the late allergen-induced asthmatic response. Respiration 2004; 71: 216-224. (Pubitemid 38608338)
32. Teran LM, Carroll MP, Frew AJ, Redington AE, Davies DE, Lindley I, Howarth PH, Church MK, Holgate ST: Leukocyte recruitment after local endobronchial allergen challenge in asthma. Relationship to procedure and to airway interleukin-8 release. Am J Respir Crit Care Med 1996; 154: 469-476. (Pubitemid 26269121)
33. Versluis M, van den Berge M, Timens W, Luijk B, Rutgers B, Lammers JW, Postma DS, Hylkema MN: Allergen inhalation decreases adenosine receptor expression in sputum and blood of asthma patients. Allergy 2008; 63: 1186-1194.
34. De Monchy JG, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, De Vries K: Bronchoalveolar eosinophilia during allergen- induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373-376. (Pubitemid 15133596)
35. Silvestri M, Oddera S, Sacco O, Balbo A, Crimi E, Rossi GA: Bronchial and bronchoalveolar inflammation in single early and dual responders after allergen inhalation challenge. Lung 1997; 175: 277-285. (Pubitemid 27260316)
36. Machado L, Stalenheim G: Factors influencing the occurrence of late bronchial reactions after allergen challenge. Allergy 1990; 45: 268-274. (Pubitemid 20169731)
37. Rock M, Yoder S, Hoskins A, Ajayi WU, Sheller JR, Dworski R: Effect of allergen challenge on the percentage of natural killer T cells in patients with atopic asthma. Ann Allergy Asthma Immunol 2009; 102: 432-437.
38. Thomas SY, Banerji A, Medoff BD, Lilly CM, Luster AD: Multiple chemokine receptors, including CCR6 and CXCR3, regulate antigen-induced T cell homing to the human asthmatic airway. J Immunol 2007; 179: 1901-1912.
39. Reynolds C, Barkans J, Clark P, Kariyawasam H, Altmann D, Kay B, Boyton R: Natural killer T cells in bronchial biopsies from human allergen challenge model of allergic asthma. J Allergy Clin Immunol 2009; 124: 860-862.
40. Brooks CR, Weinkove R, Hermans IF, van Dalen CJ, Douwes J: Invariant natural killer T cells and asthma: immunologic reality or methodologic artifact? J Allergy Clin Immunol 2010; 126: 882-885.
41. Erin EM, Jenkins GR, Kon OM, Zacharasiewicz AS, Nicholson GC, Neighbour H, Tennant RC, Tan AJ, Leaker BR, Bush A, Jose PJ, Barnes PJ, Hansel TT: Optimized dialysis and protease inhibition of sputum dithiothreitol supernatants. Am J Respir Crit Care Med 2008; 177: 132-141.
42. Wouters EF, Reynaert NL, Dentener MA, Vernooy JH: Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? Proc Am Thorac Soc 2009; 6: 638-647.